GTJA

GTJA Investment Group was founded in 2001, focusing on investment in the healthcare industry. Led by strategic equity investment, its investments cover all stages including M&A, PE, VC, and angel investment. It has a professional medical investment team, builds a healthcare industry investment ecosystem platform, and is committed to becoming a globally influential healthcare investment institution.
Its assets under management exceed RMB 20 billion, with 25 healthcare industry funds (including USD funds). It has invested in more than 140 enterprises (including over 80 healthcare enterprises) and has facilitated the successful listing of 31 enterprises.
With business based in China and facing the world, the Group has established operating centers in Shenzhen, Shanghai, Beijing, Nanjing, Hong Kong, and other places. The USD funds operated by GTJA are committed to investing in outstanding healthcare enterprises globally, connecting global capital and healthcare enterprises with China's momentum, and assisting entrepreneurs in building great enterprises.

GTJA focuses on investment in the healthcare industry and builds a healthcare resource ecosystem.
Biopharmaceuticals: biologics (antibodies, blood products, vaccines, etc.), cell therapy, small molecule innovative drugs, large-scale drugs
Medical devices: IVD (clinical chemistry diagnosis, immunoassay diagnosis, molecular diagnosis, POCT), imaging equipment, high-value consumables, high-end equipment
Medical services: third-party services (testing, pathology, etc.), specialized chain hospitals, internet healthcare, pharmaceutical commerce